CME
CME Group Inc
CME Group Inc historical holders
total: 13
Baupost Group CME Group Inc transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Seth Klarman has been an institutional investor in CME Group Inc (CME) since 2026 Q2. According to 2026 Q2 report, Seth Klarman holds 619,000 shares with a market value of roughly $136.69M representing 2.52% of their equity portfolio. The fund/company first acquired CME in 2026 Q2, initially purchasing 619,000 shares.
Does Seth Klarman still hold CME?
Yes, Seth Klarman continues to hold CME Group Inc (CME). According to their 2026 Q2 report, they maintain a position of 619,000 shares valued at approximately $136.69M, representing 2.52% of their equity portfolio.
When did Seth Klarman first invest in CME?
Seth Klarman first invested in CME Group Inc (CME) in 2026 Q2 at the reported quarter-end price of $220.83 per share, acquiring 619,000 shares in their initial purchase.
What is Seth Klarman's average cost basis for CME?
Based on historical transaction data, Seth Klarman's estimated cost basis for CME Group Inc (CME) is approximately $220.83 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $220.83
CME transactions history by Baupost Group
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.52%
|
619,000
|
$220.83
|
$136,694,000
|
new
|
+2.52%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.